India: First COVID-19 vaccine gets approval for human trials

Permission was granted after the firm submitted results from pre-clinical studies of the vaccine that demonstrated its safety and immune response, said Bharat Biotech.

COVID-19 vaccine, India, clinical trial, COVID-19 combat, COVID-19 vaccine, India, clinical trial, COVID-19 combat

India’s first COVID-19 vaccine ‘COVAXIN’ gets DCGI approval for clinical trials. Photo: Times Now News

COVAXIN, India’s first vaccine candidate against the novel coronavirus, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), has received approval from the Drug Controller General of India (DCGI) to conduct Phase I and 2 human trials. According to the vaccine maker, human clinical trials of the experimental COVID-19 are scheduled to start across the country in July 2020, reported Times Now.

The SARS-CoV-2 strain was isolated in NIV, Pune, and transferred to Bharat Biotech. The indigenous, inactivated vaccine has been developed and manufactured at Bharat Biotech’s BSL-3 (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad, India, the firm said in a release on Monday (June 29).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare, granted permission to initiate Phase I and II human trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response.

COVID-19 vaccine, India, clinical trial, COVID-19 combat, COVID-19 vaccine, India, clinical trial, COVID-19 combat
Drug Controller General of India Dr V G Somani approved Bharat Biotech’s application to conduct phase I and II clinical trials for Covaxin. Photo: Indian Express

“We are proud to announce COVAXIN, India’s first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine. The proactive support and guidance from CDSCO have enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform,” said Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech, announcing the vaccine development milestone.

According to Times Now, the company accelerated its objective in completing the comprehensive preclinical studies. Results from these studies have been promising, showing extensive safety and effective immune responses.

COVID-19 vaccine, India, clinical trial, COVID-19 combat, COVID-19 vaccine, India, clinical trial, COVID-19 combat
More and more new vaccines for COVID-10 introduced these days. Photo: Reuters

“Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic. Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India’s strength in handling the future pandemics,” said Mrs Suchitra Ella, Joint Managing Director.

Bharat Biotech’s track record in developing Vero cell culture platform technologies has been proven in several vaccines for polio, rabies, rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Apart from Covaxin, Bharat Biotech is already partnering with US-based vaccine maker FluGen and virologists at the University of Wisconsin-Madison to develop an intranasal vaccine - CoroFlu. It has also inked an exclusive deal with the Thomas Jefferson University of Philadelphia for the development of a new vaccine candidate for Covid-19, which has been invented at Jefferson using an existing deactivated rabies vaccine as a vehicle for coronavirus proteins, reported Times of India.

According to the Health Ministry, India’s total coronavirus cases reached 5,48,318 as of Monday evening. Worldwide, the novel coronavirus has now claimed at least 501,847 lives and infected as many as 10,161,240 people.

COVAXIN, India's First COVID-19 Vaccine Candidate, Set For Phase I, II Human Trials. Video: NDTV

News Related


WHO chief warns of worsening COVID-19 pandemic globally

The COVID-19 pandemic will get much worse if too many countries continue in the wrong direction, the WHO warned Monday. Read more »

17 states sue Trump administration over rule that strips visas from foreign students

17 states and DC on Monday sued to block the Trump administration from stripping foreign students of their visas if their college moves exclusively to online classes because of the coronavirus pandemic. Read more »

Vietnam repatriates 350 citizens from Australia

350 Vietnamese citizens were brought home from Australia on Tuesday, thanks to Vietnamese and Australian authorities and Vietnam Airlines. Read more »

Deputy PM talks by phone with British Foreign Secretary

During a phone conversation on Monday, Deputy Prime Minister and Foreign Minister Pham Binh Minh and British Foreign Secretary Dominic Raab agreed that relations between Vietnam and the UK are improving. Read more »

Trump leads Biden in Missouri poll

US President Donald Trump is leading his opponent Joe Biden by 7 points in Missouri, according to a You Gov poll conducted by Saint Louis University. Read more »

US Congress rejects China’s claims in East Sea

The Foreign Affairs Committees of the US Senate and House of Representatives on Monday said China's claims in the South China Sea, called the East Sea in Vietnam, have no legal basis. Read more »

Man jailed for snatching phones from foreign tourists

A Hanoi court on Monday sentenced a man to five years in jail for snatching two iPhones from Taiwanese and Danish tourists last year. Read more »

Hanoi airport taxies towards upgraded runways

The overall project involves renovating and upgrading both 11L/29R runway (1A, outdoors) and 11R / 29L runway (1B, near the tarmac); as also building three new rapid exit taxiways. Indicator lights, a drainage... Read more »

Hanoi aims to be a sci-tech hub of the country: City Party chief

In the period of 2021 – 2025, Hanoi aims to develop science, technology and innovation as a major driving force for the city’s socio-economic development. Read more »

Year-end NA session to take place over 18 days

The next National Assembly session is proposed to be held over the course of 18 days in both teleconference and in-person forms. Read more »